nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—Isoxsuprine—Phenylpropanolamine—obesity	0.199	0.415	CrCrCtD
Tolterodine—Phenprocoumon—Benzphetamine—obesity	0.0813	0.17	CrCrCtD
Tolterodine—Atomoxetine—Benzphetamine—obesity	0.0553	0.116	CrCrCtD
Tolterodine—Bromodiphenhydramine—Benzphetamine—obesity	0.0517	0.108	CrCrCtD
Tolterodine—Pheniramine—Benzphetamine—obesity	0.0506	0.106	CrCrCtD
Tolterodine—Orphenadrine—Benzphetamine—obesity	0.0406	0.085	CrCrCtD
Tolterodine—CYP2C9—Phentermine—obesity	0.0321	0.105	CbGbCtD
Tolterodine—CYP2D6—Phentermine—obesity	0.0294	0.0957	CbGbCtD
Tolterodine—CYP2C9—Bupropion—obesity	0.0273	0.089	CbGbCtD
Tolterodine—CYP2D6—Bupropion—obesity	0.025	0.0814	CbGbCtD
Tolterodine—CYP3A4—Sibutramine—obesity	0.0246	0.0803	CbGbCtD
Tolterodine—CYP2C19—Cimetidine—obesity	0.0241	0.0785	CbGbCtD
Tolterodine—CYP2D6—Methamphetamine—obesity	0.0235	0.0765	CbGbCtD
Tolterodine—CYP2C9—Cimetidine—obesity	0.02	0.0653	CbGbCtD
Tolterodine—CYP3A4—Benzphetamine—obesity	0.0187	0.0608	CbGbCtD
Tolterodine—CYP2D6—Cimetidine—obesity	0.0183	0.0597	CbGbCtD
Tolterodine—CYP3A4—Bupropion—obesity	0.0159	0.0517	CbGbCtD
Tolterodine—CYP2C19—Topiramate—obesity	0.0158	0.0514	CbGbCtD
Tolterodine—CYP3A4—Orlistat—obesity	0.0129	0.0422	CbGbCtD
Tolterodine—CYP3A4—Cimetidine—obesity	0.0117	0.038	CbGbCtD
Tolterodine—CYP3A4—Topiramate—obesity	0.00763	0.0249	CbGbCtD
Tolterodine—Xerophthalmia—Topiramate—obesity	0.00177	0.0161	CcSEcCtD
Tolterodine—Urinary retention—Phenylpropanolamine—obesity	0.0014	0.0127	CcSEcCtD
Tolterodine—Dysuria—Phendimetrazine—obesity	0.00139	0.0126	CcSEcCtD
Tolterodine—CHRM3—muscle of abdomen—obesity	0.00133	0.334	CbGeAlD
Tolterodine—Disorientation—Cimetidine—obesity	0.0013	0.0118	CcSEcCtD
Tolterodine—Delusion—Sibutramine—obesity	0.00121	0.011	CcSEcCtD
Tolterodine—Urinary retention—Cimetidine—obesity	0.00111	0.0101	CcSEcCtD
Tolterodine—Flushing—Phendimetrazine—obesity	0.0011	0.01	CcSEcCtD
Tolterodine—Delusion—Bupropion—obesity	0.00106	0.0096	CcSEcCtD
Tolterodine—Influenza-like symptoms—Bupropion—obesity	0.00105	0.00951	CcSEcCtD
Tolterodine—Palpitations—Methamphetamine—obesity	0.00104	0.00947	CcSEcCtD
Tolterodine—Hallucination—Phenylpropanolamine—obesity	0.00101	0.0092	CcSEcCtD
Tolterodine—Palpitations—Benzphetamine—obesity	0.001	0.00913	CcSEcCtD
Tolterodine—Dysuria—Diethylpropion—obesity	0.000989	0.00899	CcSEcCtD
Tolterodine—Hallucination—Phentermine—obesity	0.000968	0.0088	CcSEcCtD
Tolterodine—Memory impairment—Bupropion—obesity	0.000952	0.00865	CcSEcCtD
Tolterodine—Flushing—Phenylpropanolamine—obesity	0.000944	0.00858	CcSEcCtD
Tolterodine—Tachycardia—Methamphetamine—obesity	0.000939	0.00854	CcSEcCtD
Tolterodine—Palpitations—Phendimetrazine—obesity	0.000916	0.00832	CcSEcCtD
Tolterodine—Tachycardia—Benzphetamine—obesity	0.000906	0.00823	CcSEcCtD
Tolterodine—Dyspepsia—Methamphetamine—obesity	0.000847	0.0077	CcSEcCtD
Tolterodine—Accommodation disorder—Topiramate—obesity	0.000829	0.00753	CcSEcCtD
Tolterodine—Gastrooesophageal reflux disease—Bupropion—obesity	0.000827	0.00752	CcSEcCtD
Tolterodine—Tachycardia—Phendimetrazine—obesity	0.000825	0.0075	CcSEcCtD
Tolterodine—Constipation—Methamphetamine—obesity	0.000823	0.00748	CcSEcCtD
Tolterodine—Dyspepsia—Benzphetamine—obesity	0.000817	0.00742	CcSEcCtD
Tolterodine—Hallucination—Cimetidine—obesity	0.000802	0.00729	CcSEcCtD
Tolterodine—Dry eye—Sibutramine—obesity	0.000792	0.0072	CcSEcCtD
Tolterodine—Atomoxetine—NPY1R—obesity	0.000762	0.23	CrCbGaD
Tolterodine—Anxiety—Phenylpropanolamine—obesity	0.000751	0.00683	CcSEcCtD
Tolterodine—Palpitations—Phentermine—obesity	0.000749	0.0068	CcSEcCtD
Tolterodine—Abnormal vision—Sibutramine—obesity	0.000748	0.00679	CcSEcCtD
Tolterodine—Confusional state—Phenylpropanolamine—obesity	0.000729	0.00662	CcSEcCtD
Tolterodine—Influenza like illness—Bupropion—obesity	0.000726	0.0066	CcSEcCtD
Tolterodine—Constipation—Phendimetrazine—obesity	0.000723	0.00657	CcSEcCtD
Tolterodine—Chest pain—Phentermine—obesity	0.000721	0.00656	CcSEcCtD
Tolterodine—Hypersensitivity—Methamphetamine—obesity	0.000709	0.00644	CcSEcCtD
Tolterodine—Dry mouth—Phentermine—obesity	0.000705	0.00641	CcSEcCtD
Tolterodine—Tachycardia—Phenylpropanolamine—obesity	0.000705	0.00641	CcSEcCtD
Tolterodine—Oedema—Phentermine—obesity	0.000691	0.00628	CcSEcCtD
Tolterodine—Flatulence—Cimetidine—obesity	0.000691	0.00628	CcSEcCtD
Tolterodine—Dry eye—Bupropion—obesity	0.00069	0.00627	CcSEcCtD
Tolterodine—Hypersensitivity—Benzphetamine—obesity	0.000684	0.00621	CcSEcCtD
Tolterodine—Tachycardia—Phentermine—obesity	0.000675	0.00613	CcSEcCtD
Tolterodine—Delusion—Topiramate—obesity	0.000673	0.00611	CcSEcCtD
Tolterodine—Abdominal pain—Phendimetrazine—obesity	0.000669	0.00608	CcSEcCtD
Tolterodine—Influenza-like symptoms—Topiramate—obesity	0.000666	0.00606	CcSEcCtD
Tolterodine—Diarrhoea—Methamphetamine—obesity	0.000658	0.00598	CcSEcCtD
Tolterodine—Palpitations—Diethylpropion—obesity	0.000651	0.00592	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Sibutramine—obesity	0.000643	0.00584	CcSEcCtD
Tolterodine—Somnolence—Phenylpropanolamine—obesity	0.000642	0.00584	CcSEcCtD
Tolterodine—Dizziness—Methamphetamine—obesity	0.000636	0.00578	CcSEcCtD
Tolterodine—Diarrhoea—Benzphetamine—obesity	0.000635	0.00577	CcSEcCtD
Tolterodine—Chest pain—Diethylpropion—obesity	0.000627	0.0057	CcSEcCtD
Tolterodine—Anxiety—Diethylpropion—obesity	0.000625	0.00568	CcSEcCtD
Tolterodine—Constipation—Phenylpropanolamine—obesity	0.000618	0.00562	CcSEcCtD
Tolterodine—Dizziness—Benzphetamine—obesity	0.000614	0.00558	CcSEcCtD
Tolterodine—Dry mouth—Diethylpropion—obesity	0.000614	0.00558	CcSEcCtD
Tolterodine—Dyspepsia—Phentermine—obesity	0.000609	0.00553	CcSEcCtD
Tolterodine—Memory impairment—Topiramate—obesity	0.000607	0.00551	CcSEcCtD
Tolterodine—Disorientation—Bupropion—obesity	0.000606	0.00551	CcSEcCtD
Tolterodine—Headache—Methamphetamine—obesity	0.000603	0.00548	CcSEcCtD
Tolterodine—Arthralgia—Cimetidine—obesity	0.000597	0.00543	CcSEcCtD
Tolterodine—Fatigue—Phentermine—obesity	0.000596	0.00542	CcSEcCtD
Tolterodine—Feeling abnormal—Phenylpropanolamine—obesity	0.000595	0.00541	CcSEcCtD
Tolterodine—Anxiety—Cimetidine—obesity	0.000595	0.00541	CcSEcCtD
Tolterodine—Urinary retention—Sibutramine—obesity	0.000592	0.00538	CcSEcCtD
Tolterodine—Constipation—Phentermine—obesity	0.000591	0.00537	CcSEcCtD
Tolterodine—Dry skin—Orlistat—obesity	0.000589	0.00536	CcSEcCtD
Tolterodine—Labetalol—ADRB3—obesity	0.000587	0.177	CrCbGaD
Tolterodine—Tachycardia—Diethylpropion—obesity	0.000587	0.00534	CcSEcCtD
Tolterodine—Headache—Benzphetamine—obesity	0.000581	0.00528	CcSEcCtD
Tolterodine—Diarrhoea—Phendimetrazine—obesity	0.000579	0.00526	CcSEcCtD
Tolterodine—Confusional state—Cimetidine—obesity	0.000577	0.00525	CcSEcCtD
Tolterodine—Anaphylactic shock—Cimetidine—obesity	0.000572	0.0052	CcSEcCtD
Tolterodine—Dry skin—Sibutramine—obesity	0.00057	0.00518	CcSEcCtD
Tolterodine—Dizziness—Phendimetrazine—obesity	0.000559	0.00508	CcSEcCtD
Tolterodine—Tachycardia—Cimetidine—obesity	0.000559	0.00508	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Diethylpropion—obesity	0.000548	0.00498	CcSEcCtD
Tolterodine—Abdominal pain—Phentermine—obesity	0.000547	0.00497	CcSEcCtD
Tolterodine—Somnolence—Diethylpropion—obesity	0.000535	0.00486	CcSEcCtD
Tolterodine—Hypersensitivity—Phenylpropanolamine—obesity	0.000532	0.00484	CcSEcCtD
Tolterodine—Headache—Phendimetrazine—obesity	0.00053	0.00482	CcSEcCtD
Tolterodine—Dyspepsia—Diethylpropion—obesity	0.000529	0.00481	CcSEcCtD
Tolterodine—Gastrooesophageal reflux disease—Topiramate—obesity	0.000527	0.00479	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Cimetidine—obesity	0.000521	0.00474	CcSEcCtD
Tolterodine—Bronchitis—Sibutramine—obesity	0.000517	0.0047	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Orlistat—obesity	0.000516	0.00469	CcSEcCtD
Tolterodine—Urinary retention—Bupropion—obesity	0.000516	0.00469	CcSEcCtD
Tolterodine—Constipation—Diethylpropion—obesity	0.000514	0.00468	CcSEcCtD
Tolterodine—Somnolence—Cimetidine—obesity	0.000509	0.00462	CcSEcCtD
Tolterodine—Dysuria—Sibutramine—obesity	0.000503	0.00457	CcSEcCtD
Tolterodine—Dry skin—Bupropion—obesity	0.000497	0.00452	CcSEcCtD
Tolterodine—Asthenia—Phentermine—obesity	0.000496	0.00451	CcSEcCtD
Tolterodine—Feeling abnormal—Diethylpropion—obesity	0.000496	0.00451	CcSEcCtD
Tolterodine—Fatigue—Cimetidine—obesity	0.000493	0.00448	CcSEcCtD
Tolterodine—Constipation—Cimetidine—obesity	0.000489	0.00445	CcSEcCtD
Tolterodine—Weight increased—Sibutramine—obesity	0.000489	0.00445	CcSEcCtD
Tolterodine—Urinary tract infection—Orlistat—obesity	0.000482	0.00438	CcSEcCtD
Tolterodine—Dizziness—Phenylpropanolamine—obesity	0.000478	0.00434	CcSEcCtD
Tolterodine—Diarrhoea—Phentermine—obesity	0.000473	0.0043	CcSEcCtD
Tolterodine—Feeling abnormal—Cimetidine—obesity	0.000472	0.00429	CcSEcCtD
Tolterodine—Urinary tract infection—Sibutramine—obesity	0.000466	0.00424	CcSEcCtD
Tolterodine—Sinusitis—Orlistat—obesity	0.000465	0.00422	CcSEcCtD
Tolterodine—Influenza like illness—Topiramate—obesity	0.000462	0.0042	CcSEcCtD
Tolterodine—Dizziness—Phentermine—obesity	0.000457	0.00416	CcSEcCtD
Tolterodine—Bronchitis—Bupropion—obesity	0.000451	0.0041	CcSEcCtD
Tolterodine—Sinusitis—Sibutramine—obesity	0.00045	0.00409	CcSEcCtD
Tolterodine—Dry eye—Topiramate—obesity	0.00044	0.004	CcSEcCtD
Tolterodine—Dysuria—Bupropion—obesity	0.000438	0.00398	CcSEcCtD
Tolterodine—Oedema peripheral—Orlistat—obesity	0.000438	0.00398	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Bupropion—obesity	0.000436	0.00396	CcSEcCtD
Tolterodine—Headache—Phentermine—obesity	0.000433	0.00394	CcSEcCtD
Tolterodine—Weight increased—Bupropion—obesity	0.000427	0.00388	CcSEcCtD
Tolterodine—Oedema peripheral—Sibutramine—obesity	0.000424	0.00385	CcSEcCtD
Tolterodine—Hypersensitivity—Cimetidine—obesity	0.000422	0.00383	CcSEcCtD
Tolterodine—Abnormal vision—Topiramate—obesity	0.000415	0.00377	CcSEcCtD
Tolterodine—Visual impairment—Sibutramine—obesity	0.000415	0.00377	CcSEcCtD
Tolterodine—Diarrhoea—Diethylpropion—obesity	0.000412	0.00374	CcSEcCtD
Tolterodine—Asthenia—Cimetidine—obesity	0.000411	0.00373	CcSEcCtD
Tolterodine—Urinary tract infection—Bupropion—obesity	0.000406	0.00369	CcSEcCtD
Tolterodine—Dizziness—Diethylpropion—obesity	0.000398	0.00362	CcSEcCtD
Tolterodine—Sinusitis—Bupropion—obesity	0.000392	0.00356	CcSEcCtD
Tolterodine—Diarrhoea—Cimetidine—obesity	0.000392	0.00356	CcSEcCtD
Tolterodine—Disorientation—Topiramate—obesity	0.000386	0.00351	CcSEcCtD
Tolterodine—Flatulence—Orlistat—obesity	0.000381	0.00347	CcSEcCtD
Tolterodine—Dizziness—Cimetidine—obesity	0.000378	0.00344	CcSEcCtD
Tolterodine—Headache—Diethylpropion—obesity	0.000377	0.00342	CcSEcCtD
Tolterodine—Hallucination—Bupropion—obesity	0.000373	0.00339	CcSEcCtD
Tolterodine—Oedema peripheral—Bupropion—obesity	0.00037	0.00336	CcSEcCtD
Tolterodine—Flatulence—Sibutramine—obesity	0.000369	0.00336	CcSEcCtD
Tolterodine—Visual impairment—Bupropion—obesity	0.000362	0.00329	CcSEcCtD
Tolterodine—Headache—Cimetidine—obesity	0.000359	0.00326	CcSEcCtD
Tolterodine—Angioedema—Orlistat—obesity	0.000354	0.00322	CcSEcCtD
Tolterodine—Flushing—Bupropion—obesity	0.000348	0.00317	CcSEcCtD
Tolterodine—Vertigo—Orlistat—obesity	0.000348	0.00316	CcSEcCtD
Tolterodine—Angioedema—Sibutramine—obesity	0.000342	0.00311	CcSEcCtD
Tolterodine—Palpitations—Orlistat—obesity	0.000342	0.00311	CcSEcCtD
Tolterodine—Vertigo—Sibutramine—obesity	0.000337	0.00306	CcSEcCtD
Tolterodine—Palpitations—Sibutramine—obesity	0.000331	0.00301	CcSEcCtD
Tolterodine—Chest pain—Orlistat—obesity	0.00033	0.003	CcSEcCtD
Tolterodine—Urinary retention—Topiramate—obesity	0.000329	0.00299	CcSEcCtD
Tolterodine—Anxiety—Orlistat—obesity	0.000328	0.00299	CcSEcCtD
Tolterodine—Dry mouth—Orlistat—obesity	0.000322	0.00293	CcSEcCtD
Tolterodine—Flatulence—Bupropion—obesity	0.000322	0.00293	CcSEcCtD
Tolterodine—Arthralgia—Sibutramine—obesity	0.000319	0.0029	CcSEcCtD
Tolterodine—Chest pain—Sibutramine—obesity	0.000319	0.0029	CcSEcCtD
Tolterodine—Anxiety—Sibutramine—obesity	0.000318	0.00289	CcSEcCtD
Tolterodine—Anaphylactic shock—Orlistat—obesity	0.000316	0.00287	CcSEcCtD
Tolterodine—Oedema—Orlistat—obesity	0.000316	0.00287	CcSEcCtD
Tolterodine—Disopyramide—SLC22A1—obesity	0.000315	0.0948	CrCbGaD
Tolterodine—Infection—Orlistat—obesity	0.000314	0.00285	CcSEcCtD
Tolterodine—Dry mouth—Sibutramine—obesity	0.000312	0.00284	CcSEcCtD
Tolterodine—Confusional state—Sibutramine—obesity	0.000308	0.0028	CcSEcCtD
Tolterodine—Oedema—Sibutramine—obesity	0.000306	0.00278	CcSEcCtD
Tolterodine—Anaphylactic shock—Sibutramine—obesity	0.000306	0.00278	CcSEcCtD
Tolterodine—Infection—Sibutramine—obesity	0.000304	0.00276	CcSEcCtD
Tolterodine—Angioedema—Bupropion—obesity	0.000298	0.00271	CcSEcCtD
Tolterodine—Tachycardia—Sibutramine—obesity	0.000298	0.00271	CcSEcCtD
Tolterodine—Vertigo—Bupropion—obesity	0.000293	0.00267	CcSEcCtD
Tolterodine—Palpitations—Bupropion—obesity	0.000289	0.00262	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Orlistat—obesity	0.000288	0.00262	CcSEcCtD
Tolterodine—Bronchitis—Topiramate—obesity	0.000287	0.00261	CcSEcCtD
Tolterodine—Dysuria—Topiramate—obesity	0.000279	0.00254	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Sibutramine—obesity	0.000279	0.00253	CcSEcCtD
Tolterodine—Dyspepsia—Orlistat—obesity	0.000278	0.00253	CcSEcCtD
Tolterodine—Chest pain—Bupropion—obesity	0.000278	0.00253	CcSEcCtD
Tolterodine—Arthralgia—Bupropion—obesity	0.000278	0.00253	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Topiramate—obesity	0.000278	0.00252	CcSEcCtD
Tolterodine—Anxiety—Bupropion—obesity	0.000277	0.00252	CcSEcCtD
Tolterodine—Fatigue—Orlistat—obesity	0.000272	0.00248	CcSEcCtD
Tolterodine—Dry mouth—Bupropion—obesity	0.000272	0.00247	CcSEcCtD
Tolterodine—Somnolence—Sibutramine—obesity	0.000272	0.00247	CcSEcCtD
Tolterodine—Weight increased—Topiramate—obesity	0.000272	0.00247	CcSEcCtD
Tolterodine—Pain—Orlistat—obesity	0.00027	0.00246	CcSEcCtD
Tolterodine—Dyspepsia—Sibutramine—obesity	0.000269	0.00245	CcSEcCtD
Tolterodine—Confusional state—Bupropion—obesity	0.000269	0.00244	CcSEcCtD
Tolterodine—Anaphylactic shock—Bupropion—obesity	0.000267	0.00242	CcSEcCtD
Tolterodine—Oedema—Bupropion—obesity	0.000267	0.00242	CcSEcCtD
Tolterodine—Labetalol—ADRB1—obesity	0.000266	0.08	CrCbGaD
Tolterodine—Infection—Bupropion—obesity	0.000265	0.00241	CcSEcCtD
Tolterodine—Constipation—Sibutramine—obesity	0.000261	0.00238	CcSEcCtD
Tolterodine—Pain—Sibutramine—obesity	0.000261	0.00238	CcSEcCtD
Tolterodine—Feeling abnormal—Orlistat—obesity	0.00026	0.00237	CcSEcCtD
Tolterodine—Tachycardia—Bupropion—obesity	0.00026	0.00236	CcSEcCtD
Tolterodine—Urinary tract infection—Topiramate—obesity	0.000259	0.00235	CcSEcCtD
Tolterodine—Gastrointestinal pain—Orlistat—obesity	0.000258	0.00235	CcSEcCtD
Tolterodine—Feeling abnormal—Sibutramine—obesity	0.000252	0.00229	CcSEcCtD
Tolterodine—Gastrointestinal pain—Sibutramine—obesity	0.00025	0.00227	CcSEcCtD
Tolterodine—Sinusitis—Topiramate—obesity	0.00025	0.00227	CcSEcCtD
Tolterodine—Abdominal pain—Orlistat—obesity	0.00025	0.00227	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Bupropion—obesity	0.000243	0.00221	CcSEcCtD
Tolterodine—Abdominal pain—Sibutramine—obesity	0.000242	0.0022	CcSEcCtD
Tolterodine—Hallucination—Topiramate—obesity	0.000238	0.00216	CcSEcCtD
Tolterodine—Somnolence—Bupropion—obesity	0.000237	0.00215	CcSEcCtD
Tolterodine—Oedema peripheral—Topiramate—obesity	0.000236	0.00214	CcSEcCtD
Tolterodine—Dyspepsia—Bupropion—obesity	0.000235	0.00213	CcSEcCtD
Tolterodine—Hypersensitivity—Orlistat—obesity	0.000233	0.00212	CcSEcCtD
Tolterodine—Visual impairment—Topiramate—obesity	0.00023	0.00209	CcSEcCtD
Tolterodine—Fatigue—Bupropion—obesity	0.00023	0.00209	CcSEcCtD
Tolterodine—Chlorphenamine—SLC22A1—obesity	0.00023	0.0692	CrCbGaD
Tolterodine—Pain—Bupropion—obesity	0.000228	0.00207	CcSEcCtD
Tolterodine—Constipation—Bupropion—obesity	0.000228	0.00207	CcSEcCtD
Tolterodine—Asthenia—Orlistat—obesity	0.000227	0.00206	CcSEcCtD
Tolterodine—Hypersensitivity—Sibutramine—obesity	0.000225	0.00205	CcSEcCtD
Tolterodine—Labetalol—ADRB2—obesity	0.000223	0.0673	CrCbGaD
Tolterodine—Flushing—Topiramate—obesity	0.000222	0.00202	CcSEcCtD
Tolterodine—Feeling abnormal—Bupropion—obesity	0.00022	0.002	CcSEcCtD
Tolterodine—Asthenia—Sibutramine—obesity	0.000219	0.00199	CcSEcCtD
Tolterodine—Gastrointestinal pain—Bupropion—obesity	0.000218	0.00198	CcSEcCtD
Tolterodine—Diarrhoea—Orlistat—obesity	0.000216	0.00196	CcSEcCtD
Tolterodine—Abdominal pain—Bupropion—obesity	0.000211	0.00192	CcSEcCtD
Tolterodine—Diarrhoea—Sibutramine—obesity	0.000209	0.0019	CcSEcCtD
Tolterodine—Dizziness—Orlistat—obesity	0.000209	0.0019	CcSEcCtD
Tolterodine—Flatulence—Topiramate—obesity	0.000205	0.00186	CcSEcCtD
Tolterodine—Dizziness—Sibutramine—obesity	0.000202	0.00184	CcSEcCtD
Tolterodine—Headache—Orlistat—obesity	0.000198	0.0018	CcSEcCtD
Tolterodine—Hypersensitivity—Bupropion—obesity	0.000196	0.00179	CcSEcCtD
Tolterodine—Headache—Sibutramine—obesity	0.000192	0.00174	CcSEcCtD
Tolterodine—Asthenia—Bupropion—obesity	0.000191	0.00174	CcSEcCtD
Tolterodine—Vertigo—Topiramate—obesity	0.000187	0.0017	CcSEcCtD
Tolterodine—Palpitations—Topiramate—obesity	0.000184	0.00167	CcSEcCtD
Tolterodine—Diarrhoea—Bupropion—obesity	0.000182	0.00166	CcSEcCtD
Tolterodine—CHRM2—cardiovascular system—obesity	0.000179	0.0447	CbGeAlD
Tolterodine—KCNH2—islet of Langerhans—obesity	0.000179	0.0447	CbGeAlD
Tolterodine—Chest pain—Topiramate—obesity	0.000177	0.00161	CcSEcCtD
Tolterodine—Arthralgia—Topiramate—obesity	0.000177	0.00161	CcSEcCtD
Tolterodine—Anxiety—Topiramate—obesity	0.000177	0.0016	CcSEcCtD
Tolterodine—Dizziness—Bupropion—obesity	0.000176	0.0016	CcSEcCtD
Tolterodine—Dry mouth—Topiramate—obesity	0.000173	0.00157	CcSEcCtD
Tolterodine—Confusional state—Topiramate—obesity	0.000171	0.00156	CcSEcCtD
Tolterodine—Oedema—Topiramate—obesity	0.00017	0.00154	CcSEcCtD
Tolterodine—Infection—Topiramate—obesity	0.000169	0.00153	CcSEcCtD
Tolterodine—CYP2D6—hindbrain—obesity	0.000168	0.0421	CbGeAlD
Tolterodine—Headache—Bupropion—obesity	0.000167	0.00152	CcSEcCtD
Tolterodine—Tachycardia—Topiramate—obesity	0.000166	0.00151	CcSEcCtD
Tolterodine—Atomoxetine—HTR1B—obesity	0.000165	0.0499	CrCbGaD
Tolterodine—CHRM1—cardiovascular system—obesity	0.000163	0.0407	CbGeAlD
Tolterodine—Musculoskeletal discomfort—Topiramate—obesity	0.000155	0.00141	CcSEcCtD
Tolterodine—Somnolence—Topiramate—obesity	0.000151	0.00137	CcSEcCtD
Tolterodine—Dyspepsia—Topiramate—obesity	0.00015	0.00136	CcSEcCtD
Tolterodine—Fatigue—Topiramate—obesity	0.000146	0.00133	CcSEcCtD
Tolterodine—Pain—Topiramate—obesity	0.000145	0.00132	CcSEcCtD
Tolterodine—Constipation—Topiramate—obesity	0.000145	0.00132	CcSEcCtD
Tolterodine—Feeling abnormal—Topiramate—obesity	0.00014	0.00127	CcSEcCtD
Tolterodine—Gastrointestinal pain—Topiramate—obesity	0.000139	0.00126	CcSEcCtD
Tolterodine—Atomoxetine—HTR2C—obesity	0.000135	0.0406	CrCbGaD
Tolterodine—Abdominal pain—Topiramate—obesity	0.000134	0.00122	CcSEcCtD
Tolterodine—Chlorphenamine—SLC6A4—obesity	0.000133	0.0401	CrCbGaD
Tolterodine—Brompheniramine—CYP2E1—obesity	0.00013	0.0391	CrCbGaD
Tolterodine—KCNH2—cardiovascular system—obesity	0.000129	0.0323	CbGeAlD
Tolterodine—CHRM3—adipose tissue—obesity	0.000128	0.0321	CbGeAlD
Tolterodine—Hypersensitivity—Topiramate—obesity	0.000125	0.00114	CcSEcCtD
Tolterodine—CHRM2—endocrine gland—obesity	0.000123	0.0307	CbGeAlD
Tolterodine—Asthenia—Topiramate—obesity	0.000122	0.00111	CcSEcCtD
Tolterodine—CHRM3—digestive system—obesity	0.000121	0.0302	CbGeAlD
Tolterodine—Diarrhoea—Topiramate—obesity	0.000116	0.00106	CcSEcCtD
Tolterodine—KCNH2—pituitary gland—obesity	0.000114	0.0286	CbGeAlD
Tolterodine—CYP2C19—digestive system—obesity	0.000112	0.0281	CbGeAlD
Tolterodine—Dizziness—Topiramate—obesity	0.000112	0.00102	CcSEcCtD
Tolterodine—Atomoxetine—SLC6A4—obesity	0.000112	0.0337	CrCbGaD
Tolterodine—CHRM1—endocrine gland—obesity	0.000112	0.0279	CbGeAlD
Tolterodine—Headache—Topiramate—obesity	0.000106	0.000967	CcSEcCtD
Tolterodine—CYP2C9—cardiovascular system—obesity	0.000105	0.0263	CbGeAlD
Tolterodine—KCNH2—adrenal gland—obesity	0.000102	0.0256	CbGeAlD
Tolterodine—CHRM3—endocrine gland—obesity	9.99e-05	0.025	CbGeAlD
Tolterodine—Phenprocoumon—ALB—obesity	9.4e-05	0.0283	CrCbGaD
Tolterodine—CYP2C19—endocrine gland—obesity	9.28e-05	0.0232	CbGeAlD
Tolterodine—KCNH2—endocrine gland—obesity	8.86e-05	0.0222	CbGeAlD
Tolterodine—CYP2C9—digestive system—obesity	8.71e-05	0.0218	CbGeAlD
Tolterodine—Atomoxetine—HTR2A—obesity	8.59e-05	0.0259	CrCbGaD
Tolterodine—CYP2C19—liver—obesity	8.37e-05	0.0209	CbGeAlD
Tolterodine—Orphenadrine—CYP2E1—obesity	8.17e-05	0.0246	CrCbGaD
Tolterodine—CYP2C9—endocrine gland—obesity	7.2e-05	0.018	CbGeAlD
Tolterodine—CYP3A4—digestive system—obesity	6.64e-05	0.0166	CbGeAlD
Tolterodine—CYP2D6—digestive system—obesity	6.54e-05	0.0164	CbGeAlD
Tolterodine—CYP2C9—liver—obesity	6.49e-05	0.0162	CbGeAlD
Tolterodine—CYP3A4—endocrine gland—obesity	5.49e-05	0.0137	CbGeAlD
Tolterodine—CYP2D6—endocrine gland—obesity	5.4e-05	0.0135	CbGeAlD
Tolterodine—CYP3A4—liver—obesity	4.95e-05	0.0124	CbGeAlD
Tolterodine—CYP2D6—liver—obesity	4.87e-05	0.0122	CbGeAlD
Tolterodine—CYP2D6—Metabolism—COMT—obesity	3.26e-06	3.35e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CD—obesity	3.25e-06	3.34e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PRKCB—obesity	3.24e-06	3.33e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—F2—obesity	3.24e-06	3.33e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ESR1—obesity	3.24e-06	3.33e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PRKCB—obesity	3.23e-06	3.32e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—F2—obesity	3.23e-06	3.32e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—COMT—obesity	3.23e-06	3.32e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—obesity	3.22e-06	3.31e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CPT1A—obesity	3.22e-06	3.3e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GNB3—obesity	3.21e-06	3.3e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARGC1A—obesity	3.21e-06	3.3e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ALB—obesity	3.21e-06	3.3e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—BAD—obesity	3.21e-06	3.29e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—F2—obesity	3.2e-06	3.29e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PRKCB—obesity	3.2e-06	3.29e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HMOX1—obesity	3.2e-06	3.29e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—BAD—obesity	3.2e-06	3.28e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARGC1A—obesity	3.19e-06	3.27e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GNB3—obesity	3.19e-06	3.27e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—LPL—obesity	3.18e-06	3.27e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HMOX1—obesity	3.17e-06	3.26e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—BAD—obesity	3.17e-06	3.25e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NAMPT—obesity	3.15e-06	3.24e-05	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—AKT1—obesity	3.14e-06	3.22e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—LIPC—obesity	3.13e-06	3.22e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GCK—obesity	3.13e-06	3.22e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GNAS—obesity	3.13e-06	3.21e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOC3—obesity	3.12e-06	3.2e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CG—obesity	3.11e-06	3.19e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GPX1—obesity	3.1e-06	3.19e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GNAS—obesity	3.1e-06	3.19e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CG—obesity	3.1e-06	3.18e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—obesity	3.09e-06	3.17e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—NOS3—obesity	3.07e-06	3.16e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3R1—obesity	3.07e-06	3.16e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IRS1—obesity	3.07e-06	3.15e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MMP9—obesity	3.07e-06	3.15e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CG—obesity	3.07e-06	3.15e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOB—obesity	3.06e-06	3.15e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IRS1—obesity	3.06e-06	3.14e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOB—obesity	3.04e-06	3.12e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IRS1—obesity	3.03e-06	3.11e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CETP—obesity	3.02e-06	3.11e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CD36—obesity	3.02e-06	3.1e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SDC1—obesity	2.99e-06	3.07e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MAPK8—obesity	2.98e-06	3.06e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—AKT1—obesity	2.97e-06	3.06e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—POMC—obesity	2.96e-06	3.04e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—POMC—obesity	2.95e-06	3.03e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKR1C3—obesity	2.94e-06	3.02e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—INS—obesity	2.94e-06	3.02e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MMP9—obesity	2.94e-06	3.02e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—INS—obesity	2.93e-06	3.01e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—LPL—obesity	2.93e-06	3e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—POMC—obesity	2.92e-06	3e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—INS—obesity	2.9e-06	2.98e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—LPL—obesity	2.9e-06	2.98e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SCARB1—obesity	2.9e-06	2.97e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL2—obesity	2.89e-06	2.97e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL2—obesity	2.88e-06	2.96e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MTHFR—obesity	2.86e-06	2.94e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MAPK8—obesity	2.86e-06	2.93e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL2—obesity	2.85e-06	2.93e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GPX1—obesity	2.85e-06	2.93e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—AKT1—obesity	2.85e-06	2.93e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF1—obesity	2.84e-06	2.92e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKT2—obesity	2.84e-06	2.92e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CB—obesity	2.84e-06	2.91e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF1—obesity	2.83e-06	2.91e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKT2—obesity	2.83e-06	2.91e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GPX1—obesity	2.83e-06	2.91e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SREBF1—obesity	2.81e-06	2.89e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTGS2—obesity	2.81e-06	2.89e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARA—obesity	2.81e-06	2.89e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF1—obesity	2.81e-06	2.88e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKT2—obesity	2.8e-06	2.88e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CD36—obesity	2.78e-06	2.86e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CD36—obesity	2.76e-06	2.83e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GOT2—obesity	2.74e-06	2.81e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CD—obesity	2.73e-06	2.8e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—STAT3—obesity	2.73e-06	2.8e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AGT—obesity	2.72e-06	2.79e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CD—obesity	2.72e-06	2.79e-05	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—PIK3CA—obesity	2.7e-06	2.78e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SERPINE1—obesity	2.7e-06	2.77e-05	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—PIK3CA—obesity	2.7e-06	2.77e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CD—obesity	2.69e-06	2.77e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SERPINE1—obesity	2.69e-06	2.76e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—FASN—obesity	2.68e-06	2.75e-05	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—PIK3CA—obesity	2.67e-06	2.74e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOE—obesity	2.67e-06	2.74e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—BCHE—obesity	2.67e-06	2.74e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SERPINE1—obesity	2.67e-06	2.74e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CAV1—obesity	2.64e-06	2.71e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOA1—obesity	2.64e-06	2.71e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MTHFR—obesity	2.63e-06	2.71e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TYK2—obesity	2.63e-06	2.7e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TYK2—obesity	2.62e-06	2.69e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MTHFR—obesity	2.61e-06	2.68e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—STAT3—obesity	2.61e-06	2.68e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RHOA—obesity	2.6e-06	2.67e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RHOA—obesity	2.6e-06	2.67e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TYK2—obesity	2.59e-06	2.66e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARA—obesity	2.58e-06	2.65e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NOS3—obesity	2.58e-06	2.65e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3R1—obesity	2.58e-06	2.65e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP2E1—obesity	2.57e-06	2.64e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RHOA—obesity	2.57e-06	2.64e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NOS3—obesity	2.57e-06	2.64e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3R1—obesity	2.57e-06	2.64e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARA—obesity	2.56e-06	2.63e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NOS3—obesity	2.54e-06	2.61e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3R1—obesity	2.54e-06	2.61e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NQO1—obesity	2.54e-06	2.61e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MYC—obesity	2.53e-06	2.6e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TGFB1—obesity	2.53e-06	2.6e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.52e-06	2.59e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AGT—obesity	2.5e-06	2.57e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AGT—obesity	2.48e-06	2.55e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PIK3CA—obesity	2.46e-06	2.52e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOE—obesity	2.45e-06	2.52e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—PIK3CA—obesity	2.45e-06	2.51e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GCG—obesity	2.44e-06	2.5e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SLC2A4—obesity	2.44e-06	2.5e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOE—obesity	2.43e-06	2.5e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CAV1—obesity	2.43e-06	2.5e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MYC—obesity	2.43e-06	2.49e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOA1—obesity	2.42e-06	2.49e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PIK3CA—obesity	2.42e-06	2.49e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TGFB1—obesity	2.42e-06	2.49e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CAV1—obesity	2.41e-06	2.47e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CG—obesity	2.41e-06	2.47e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYCS—obesity	2.41e-06	2.47e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOA1—obesity	2.4e-06	2.47e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MTOR—obesity	2.38e-06	2.44e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CB—obesity	2.38e-06	2.44e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MTOR—obesity	2.37e-06	2.44e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CB—obesity	2.37e-06	2.44e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GOT1—obesity	2.36e-06	2.42e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GGT1—obesity	2.36e-06	2.42e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CB—obesity	2.35e-06	2.41e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MTOR—obesity	2.35e-06	2.41e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NCOA1—obesity	2.33e-06	2.39e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARG—obesity	2.32e-06	2.39e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.3e-06	2.36e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—STK11—obesity	2.29e-06	2.35e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP19A1—obesity	2.29e-06	2.35e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—POMC—obesity	2.29e-06	2.35e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—INS—obesity	2.28e-06	2.34e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CG—obesity	2.21e-06	2.27e-05	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—AKT1—obesity	2.21e-06	2.27e-05	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—AKT1—obesity	2.2e-06	2.26e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CG—obesity	2.19e-06	2.25e-05	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—AKT1—obesity	2.18e-06	2.24e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—obesity	2.17e-06	2.23e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—obesity	2.17e-06	2.23e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PIK3CA—obesity	2.15e-06	2.21e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—obesity	2.15e-06	2.2e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARG—obesity	2.14e-06	2.19e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—COMT—obesity	2.13e-06	2.19e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARG—obesity	2.12e-06	2.17e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CD—obesity	2.12e-06	2.17e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—POMC—obesity	2.11e-06	2.16e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARGC1A—obesity	2.1e-06	2.16e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GNB3—obesity	2.1e-06	2.16e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—INS—obesity	2.1e-06	2.15e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HMOX1—obesity	2.09e-06	2.15e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—POMC—obesity	2.09e-06	2.15e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ALB—obesity	2.09e-06	2.14e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—INS—obesity	2.08e-06	2.13e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MMP9—obesity	2.07e-06	2.12e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MMP9—obesity	2.06e-06	2.12e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PIK3CA—obesity	2.06e-06	2.12e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GNAS—obesity	2.05e-06	2.1e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MMP9—obesity	2.04e-06	2.1e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MAPK8—obesity	2.01e-06	2.07e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—AKT1—obesity	2.01e-06	2.06e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MAPK8—obesity	2.01e-06	2.06e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOB—obesity	2e-06	2.06e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—AKT1—obesity	2e-06	2.05e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3R1—obesity	2e-06	2.05e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NOS3—obesity	2e-06	2.05e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MAPK8—obesity	1.99e-06	2.04e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—AKT1—obesity	1.98e-06	2.03e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CD—obesity	1.95e-06	2e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CD—obesity	1.93e-06	1.98e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ALB—obesity	1.92e-06	1.97e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—LPL—obesity	1.91e-06	1.96e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—obesity	1.9e-06	1.96e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ALB—obesity	1.9e-06	1.96e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GPX1—obesity	1.87e-06	1.92e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CB—obesity	1.84e-06	1.89e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—STAT3—obesity	1.84e-06	1.89e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NOS3—obesity	1.84e-06	1.89e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3R1—obesity	1.84e-06	1.89e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—STAT3—obesity	1.83e-06	1.88e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGS2—obesity	1.83e-06	1.88e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—obesity	1.82e-06	1.87e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3R1—obesity	1.82e-06	1.87e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NOS3—obesity	1.82e-06	1.87e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CD36—obesity	1.82e-06	1.87e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—STAT3—obesity	1.82e-06	1.86e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AKT1—obesity	1.76e-06	1.8e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CA—obesity	1.73e-06	1.78e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MTHFR—obesity	1.72e-06	1.77e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MYC—obesity	1.71e-06	1.75e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TGFB1—obesity	1.7e-06	1.75e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MYC—obesity	1.7e-06	1.75e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TGFB1—obesity	1.7e-06	1.74e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CB—obesity	1.7e-06	1.74e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARA—obesity	1.69e-06	1.74e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MYC—obesity	1.69e-06	1.73e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AKT1—obesity	1.68e-06	1.73e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TGFB1—obesity	1.68e-06	1.73e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CB—obesity	1.68e-06	1.73e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGS2—obesity	1.68e-06	1.73e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGS2—obesity	1.67e-06	1.71e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AGT—obesity	1.64e-06	1.68e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOE—obesity	1.6e-06	1.65e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CAV1—obesity	1.59e-06	1.63e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOA1—obesity	1.59e-06	1.63e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CA—obesity	1.45e-06	1.49e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CG—obesity	1.45e-06	1.49e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CA—obesity	1.45e-06	1.48e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CA—obesity	1.43e-06	1.47e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—AKT1—obesity	1.41e-06	1.45e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARG—obesity	1.4e-06	1.43e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—POMC—obesity	1.38e-06	1.41e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—INS—obesity	1.37e-06	1.41e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—obesity	1.28e-06	1.32e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—obesity	1.28e-06	1.31e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CD—obesity	1.27e-06	1.31e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—obesity	1.27e-06	1.3e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ALB—obesity	1.26e-06	1.29e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3R1—obesity	1.2e-06	1.23e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NOS3—obesity	1.2e-06	1.23e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKT1—obesity	1.18e-06	1.22e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKT1—obesity	1.18e-06	1.21e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKT1—obesity	1.17e-06	1.2e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CA—obesity	1.12e-06	1.15e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CB—obesity	1.11e-06	1.14e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS2—obesity	1.1e-06	1.13e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CA—obesity	1.03e-06	1.06e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CA—obesity	1.02e-06	1.05e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AKT1—obesity	9.18e-07	9.43e-06	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AKT1—obesity	8.45e-07	8.67e-06	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AKT1—obesity	8.37e-07	8.6e-06	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CA—obesity	6.76e-07	6.94e-06	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKT1—obesity	5.52e-07	5.67e-06	CbGpPWpGaD
